222 related articles for article (PubMed ID: 28786256)
1. Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency.
Pedini V; Savore I; Danieli MG
Isr Med Assoc J; 2017 Jul; 19(7):420-423. PubMed ID: 28786256
[TBL] [Abstract][Full Text] [Related]
2. Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency.
Ramyar A; Aghamohammadi A; Moazzami K; Rezaei N; Yeganeh M; Cheraghi T; Pouladi N; Heydari G; Abolhassani H; Amirzargar AA; Parvaneh N; Moin M
Iran J Allergy Asthma Immunol; 2008 Sep; 7(3):169-75. PubMed ID: 18780952
[TBL] [Abstract][Full Text] [Related]
3. [Primary immunodeficiencies presenting with autoimmune cytopenias in adults].
Sève P; Broussolle C; Pavic M
Rev Med Interne; 2013 Mar; 34(3):148-53. PubMed ID: 22703729
[TBL] [Abstract][Full Text] [Related]
4. [Recurrent infections in an ITP patient treated with rituximab].
Rosenberg-Bezalel S; Asher I; Sthoeger Z
Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
[TBL] [Abstract][Full Text] [Related]
5. A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement.
Więsik-Szewczyk E; Jahnz-Różyk K
Medicine (Baltimore); 2018 Nov; 97(44):e12804. PubMed ID: 30383634
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature.
Michel M; Chanet V; Galicier L; Ruivard M; Levy Y; Hermine O; Oksenhendler E; Schaeffer A; Bierling P; Godeau B
Medicine (Baltimore); 2004 Jul; 83(4):254-263. PubMed ID: 15232313
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of ITP and AIHA in CVID: A systematic literature review].
Lacombe V; Lozac'h P; Orvain C; Lavigne C; Miot C; Pellier I; Urbanski G
Rev Med Interne; 2019 Aug; 40(8):491-500. PubMed ID: 31101329
[TBL] [Abstract][Full Text] [Related]
8. Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies.
Danieli MG; Pulvirenti F; Rocchi V; Morariu R; Quinti I
Immunotherapy; 2016 Sep; 8(9):995-1002. PubMed ID: 27485073
[TBL] [Abstract][Full Text] [Related]
9. Facilitated subcutaneous immunoglobulin (fSCIg) therapy--practical considerations.
Ponsford M; Carne E; Kingdon C; Joyce C; Price C; Williams C; El-Shanawany T; Williams P; Jolles S
Clin Exp Immunol; 2015 Dec; 182(3):302-13. PubMed ID: 26288095
[TBL] [Abstract][Full Text] [Related]
10. Effects of Body Mass and Age on the Pharmacokinetics of Subcutaneous or Hyaluronidase-facilitated Subcutaneous Immunoglobulin G in Primary Immunodeficiency Diseases.
Li Z; Follman K; Freshwater E; Engler F; Yel L
J Clin Immunol; 2023 Nov; 43(8):2127-2135. PubMed ID: 37773562
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy, safety, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin (Ig) (fSCIG; HyQvia(
Angelotti F; Capecchi R; Giannini D; Mazzarella O; Rocchi V; Migliorini P
Clin Exp Med; 2020 Aug; 20(3):387-392. PubMed ID: 32385734
[TBL] [Abstract][Full Text] [Related]
12. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID).
Wang J; Cunningham-Rundles C
J Autoimmun; 2005 Aug; 25(1):57-62. PubMed ID: 15994061
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune Cytopenias and Associated Conditions in CVID: a Report From the USIDNET Registry.
Feuille EJ; Anooshiravani N; Sullivan KE; Fuleihan RL; Cunningham-Rundles C
J Clin Immunol; 2018 Jan; 38(1):28-34. PubMed ID: 29080979
[TBL] [Abstract][Full Text] [Related]
14. Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration.
Zama D; Conti F; Moratti M; Cantarini ME; Facchini E; Rivalta B; Rondelli R; Prete A; Ferrari S; Seri M; Pession A
Immun Inflamm Dis; 2021 Jun; 9(2):583-594. PubMed ID: 33838017
[TBL] [Abstract][Full Text] [Related]
15. Facilitated Subcutaneous Immunoglobulin Replacement Therapy in Clinical Practice: A Two Center, Long-Term Retrospective Observation in Adults With Primary Immunodeficiencies.
Wiesik-Szewczyk E; Sołdacki D; Paczek L; Jahnz-Różyk K
Front Immunol; 2020; 11():981. PubMed ID: 32670265
[TBL] [Abstract][Full Text] [Related]
16. Facilitated Subcutaneous Immunoglobulin Treatment Increases the Quality of Life and Decreases the Number of Infections and Hospitalizations in Children with Primary Immunodeficiencies.
Erbaş Açıcı N; Topyildiz E; Aygün A; Geyik M; Edeer Karaca N; Aksu G; Kutukculer N
Int Arch Allergy Immunol; 2024; 185(4):382-391. PubMed ID: 38246144
[TBL] [Abstract][Full Text] [Related]
17. Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 cases.
Speth F; Haas JP; Hinze CH
Pediatr Rheumatol Online J; 2016 Sep; 14(1):52. PubMed ID: 27623619
[TBL] [Abstract][Full Text] [Related]
18. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency.
Carbone J; Escudero A; Mayayo M; Ballesteros M; Perez-Corral A; Sanchez-Ramon S; Sarmiento E; Micheloud D; Fernandez-Cruz E
Ann N Y Acad Sci; 2005 Jun; 1051():666-71. PubMed ID: 16127007
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura in pediatric solid organ transplant recipients, report of five cases and review of the literature.
Miloh T; Arnon R; Roman E; Hurlet A; Kerkar N; Wistinghausen B
Pediatr Transplant; 2011 Dec; 15(8):870-8. PubMed ID: 22112003
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune diseases associated with common variable immune deficiency.
Lenti MV; Savioli J; Achilli G; Di Sabatino A
Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26():60-62. PubMed ID: 33236426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
